Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.

Kennedy VE, Savani BN, Greer JP, Kassim AA, Engelhardt BG, Goodman SA, Sengsayadeth S, Chinratanalab W, Jagasia M
Biol Blood Marrow Transplant. 2016 22 (10): 1801-1807

PMID: 27377900 · DOI:10.1016/j.bbmt.2016.06.029

MeSH Terms (19)

Adult Aged Antineoplastic Combined Chemotherapy Protocols Busulfan Calcineurin Inhibitors Cyclophosphamide Graft vs Host Disease Hematopoietic Stem Cell Transplantation Humans Leukemia, B-Cell Methotrexate Middle Aged Prognosis Retrospective Studies Rituximab Survival Analysis Transplantation, Homologous Transplantation Conditioning Vidarabine

Connections (1)

This publication is referenced by other Labnodes entities: